Abstract
It is during our intrauterine development that many of the traits and characteristics that will affect our postnatal performance are established. At the time of fertilization, our genotype is established, but during fetal life, our further growth and development are influenced by many factors, including fetal genotype, placental function, local growth factors, circulating hormones, and the maternal environment. In North America, growth retardation leading to babies that are small for gestational age occurs in about 6% of all pregnancies. Preterm delivery occurs in 8–10% of all deliveries. Birth too soon of an infant that is very immature may be associated with conditions, such as cerebral palsy, and with respiratory distress syndrome in the newborn. In the US, the cost of preterm delivery—reflected in the cost of caring for these babies in Neonatal Intensive Care Units (NICUs)—has been estimated at $5–6 billion annually. The emotional cost for parents and families is substantial. Babies born too small may have additional longer-term problems. Recently, David Barker and colleagues have demonstrated that weight at birth is a powerful indicator of predisposition to disease in adult life (see Barker, 1994). The infant who is born inappropriately small has a much higher risk of developing high blood pressure, Type II diabetes, and of dying from cardiovascular disease in adult life. This relationship is particularly strong if the fetal growth reduction is asymmetrical and the placenta is disproportionately large. These relationships—small birthweight and subsequent hyper tension—can be reproduced in the offspring of rats fed low-protein diets or treated with glucocorticoids during pregnancy. Thus, understanding factors regulating pregnancy and pregnancy outcome as well as fetal growth and development are crucial for understanding, and potentially treating and preventing, diseases that may continue to affect us lifelong.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Ogren L, Talamantes F. The placenta as an endocrine organ: polypeptides. In: ( Knobil E and Neill JD, eds.) The Physiology of Reproduction, vol. 2, 2nd ed. New York: Raven 1994: 875.
Pepe GJ, Albrecht ED. Actions of placental and fetal adrenal steroid hormones in primate pregnancy. Endoc Rev 1995; 16: 608.
Selected Readings
Barker DJP. Mothers, Babies, and Disease in Later Life. London: BMJ Publishing Group, 1994.
Bassett JM, Thorburn GD. Foetal plasma corticosteroids and the initiation of parturition in the sheep. J Endocrinol 1969; 44: 285.
Benirschke K, Kaufmann P. Pathology of the Human Placenta, 2nd ed. New York: Springer-Verlag, 1990.
Challis JRG, Lye SJ. Parturition. In: ( Knobil E and Neill JD, eds.) The Physiology of Reproduction, vol. 2, 2nd ed. New York: Raven, 1994: 985.
Challis JRG, Matthews SG, van Meir C, Ramirez MM. Current topic: The placental corticotrophin-releasing hormoneadrenocorticotrophin axis. Placenta 1995; 16: 481.
Guissani DA, Jenkins SL, Winter JA, Mecenas CA, Wu WX, Umscheid CA, Farber DM, Nathanielsz PW. Differences in androstenedione (AT) and estradiol treatment (ET) in pregnant monkeys: effects on myometrial activity patterns (MyoAP), time to delivery and maternal estradiol (E2) oxytocin (OT) and progesterone (P) plasma levels. J Soc Gynecol Invest 1996; 3(2) suppl: 86 abstract.
Liggins GC, Fairclough RJ, Grieves SA, Forster CS, Knox BS. Parturition in the sheep. In: A Ciba Foundation Symposium. The Fetus and Birth. The Netherlands: Mouton, 1977: 5.
Matthews SG, Lü F, Yang K, Challis JRG. Hypothalamic pituitary adrenal function in the sheep fetus. Reprod Fertil Dev 1995; 7: 509.
Petraglia F, Florio P, Nappi C, Genazzani AR. Peptide signaling in human placenta and membranes: Autocrine, paracrine, and endocrine mechanisms. Endocrine Reviews 1996; 17: 156–186.
Ramsey EM. The Placenta, Human and Animal. New York: Praeger, 1982.
Sangha RK, Walton JC, Ensor CM, Tai H-H, Challis JRG. Immunohistochemical localization, messenger ribonucleic acid abundance, and activity of 15-hydroxyprostaglandin dehydrogenase in placenta and fetal membranes during term and preterm labor. J Clin Endocrinol Metab. 1993; 78: 982.
Short RV. Implantation and the maternal recognition of preg- nancy. In: Foetal Autonomy, London: Churchill, 1969: 2.
Stewart HJ, Guesdon FMJ, Payne JH, Charleston B, Vallet JL, Flint APF. Trophoblast interferons in early pregnancy of domestic ruminants. In: Brooks N, Challis J, McNeilly A, Doboroka C, eds. Frontiers in Reproductive Biology. Journals of Reproduction and Fertility Ltd., Cambridge: 1992: 59.
van Meir CA, Matthews SG, Ramirez MM, Calder AA, Keirse JNC, Challis JRG. Chorionic prostaglandin catabolism is decreased in the lower uterine segment with term labor. Placenta (in press), 1996.
Yen SSC. Endocrinology of Pregnancy. In: Creasy R, Resnik, R. Maternal Fetal Medicine, Principles and Practice, 3rd ed., Philadelphia: W.B. Saunders Co., 1994: 382.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media New York
About this chapter
Cite this chapter
Challis, J.R.G. (1997). Regulation of Pregnancy, Parturition, and Lactation. In: Conn, P.M., Melmed, S. (eds) Endocrinology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-641-6_27
Download citation
DOI: https://doi.org/10.1007/978-1-59259-641-6_27
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4757-5137-6
Online ISBN: 978-1-59259-641-6
eBook Packages: Springer Book Archive